Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus

Virology

Volumn 263, Issue 2, 1999, Pages 436-449

  Seaman, William T ^a   Ye, Dongsheng ^a   Wang, Rui Xue ^a   Hale, Evelyn E ^b   Weisse, Marie ^b   Quinlivan, E Byrd ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; CYCLOHEXIMIDE; HYBRID PROTEIN;

ARTICLE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0033604293     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9963     Document Type: Article

References (50)

1. Aluigi M. G., Albini A., Carlone S., Repetto L., Demarchi R., Icardi A., Moro M. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. Res. Virol. 147:1996;267-275.
2. Ambroziak J. A., Blackbourne D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 268:1995;582-583.
3. Baeuerle P. A., Baltimore D. I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science. 242:1988;540-546.
4. Baumann M., Mischak H., Dammeier S., Kolch W., Gires O., Pich D., Zeidler R., Delecluse H. J., Hammerschmidt N. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradeanoylphorbol-13-acetate-induced phosphorylation. J. Virol. 72:1998;8105-8114.
5. Bermudez-Cruz R. Characterization of an abundant, unique 1.7 kilobase bovine herpesvirus 4 (BHV-4) late RNA and mapping of a BHV-4 IE2 transactivator-binding site in its promoter-regulatory region. J. Virol. 71:1997;527-538.
6. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N. H., Tschachler E., Colombini S., Ensoli B., Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:1997;7963-7968.
7. Bublot M., Lomonte P., Lequarre A.-S., Albrecht J.-C., Nicholas J., Fleckenstein B., Pastoret P.-P., Thiry E. Genetic relationships between bovine herpesvirus 4 and the gammaherpesvirus Epstein-Barr virus and herpesvirus saimiri. Virol. 190:1992;654-665.
8. Buonoguuro F. M., Tornesello M. L., Beth-Giraldo E., Hatzakis A., Mueller N., Downing R., Biryamwaho B., Sempala S. D. K., Giraldo G. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer. 65:1996;25-28.
9. Cesarman E., Knowles D. M. Kaposi's sarcoma-associated herpesvirus: A lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin. Diagn. Pathol. 14:1997;54-66.
10. Chandran B., Bloomer C., Chan S. R., Zhu L. J., Goldstein E., Horvat R. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology. 249:1998;140-149.
11. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
12. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7:1987;2745-2752.
13. de Lellis L., Fabris M., Cassai E., Corallini A., Giraldo G., Feo C., Monini P. Herpes-like DNA in non-AIDS Kaposi's sarcoma. J. Infect. Dis. 172:1995;1605-1607.
14. Dupin N., Gorin I., Deleuze J., Agut H., Huraux J. M., Escande J. P. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N. Engl. J. Med. 333:1995;798-799.
15. Ekman M., Kaaya E. E., Schalling M., Colombini S., Ensoli B., Gallo R. C., Biberfeld P. Herpesvirus-like (KSHV) DNA in various forms of Kaposi's sarcoma (KS) and malignant lymphoma (ML). AIDS Res. Human R. 11:1995.
16. Flemington E. K., Borras A. M., Lytle J. P., Speck S. H. Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J. Virol. 66:1992;922-929.
17. Frebourg T., Brison O. Plasmid vectors with multiple cloning sites and CAT-reporter gene for promoter cloning and analysis in animal cells. Gene. 65:1988;315-318.
18. Furnari F. B., Zacny V., Quinlivan E. B., Kenney S., Pagano J. S. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J. Virol. 68:1994;1827-1836.
19. Gruffat H., Duran N., Buisson M., Wild F., Buckland R., Sergeant A. Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promotor. J. Virol. 661:1992;46-52.
20. Hardwick J. M., Tse L., Applegren N., Nicholas J., Veliuona M. A. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J. Virol. 66:1992;5500-5508.
21. Holley-Guthrie E. A., Quinlivan E. B., Kenney S. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J. Virol. 64:1990;3753-3759.
22. Kenney S., Holley-Guthrie E., Mar E. C., Smith M. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63:1989;3878-3883.
23. Kieff, E.1996. Epstein-Barr virus replication. InVirology (D. Knipe, Ed.), pp. 2343-2397. Raven Press, Ltd. New York.
24. Kouzarides T., Packham G., Cook A., Farrell P. J. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene. 6:1991;195-204.
25. Lennette E. T., Blackbourne D. J., Levy J. A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 348:1996;858-861.
26. Lin S.-F., Robinson D. R., Miller G., Kung H.-J. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73:1999;1909-1917.
27. Lukac D. M., Renne R., Kirshner J. R., Ganem D. Reactivation to Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology. 252:1998;304-312.
28. Ma J., Ptashine M. Deletion analysis of GAL4 defines two transcriptional activating sequences. Cell. 48:1987;847-853.
29. Manet E., Gruffat H., Trescol-Biemont M. C., Moreno N., Chambard P., Giot J. F., Sergeant A. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators. EMBO J. 8:1989;1819-1826.
30. Meinl E., Hohlfeld R., Wekerle H. Immortalization of human T cells by herpesvirus saimiri. Immunol. Today. 16:1995;55-58.
31. Moore P. S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332:1995;1181-1185.
32. Moore P. S., Kingsley L. A., Holmberg S. D., Spira T., Gupta P., Hoover D. R., Parry J. P., Conley L. J., Jaffe H. W., Chang Y. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 10:1996;175-180.
33. Neipel F., Albrecht J. C., Fleckenstein B. Cell-homologous genes in the Kaposi's-sarcoma-associated rhadinovirus human herpesvirus 8-determinants of its pathogenicity. J. Virol. 71:1997;4187-4192.
34. Orenstein J. M., Alkan S., Blauvelt A., Jeang K. T., Weinstein M. D., Ganem D. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS. 11:1997;F35-F45.
35. Quinlivan E. B., Holley-Guthrie E., Mar E. C., Smith M. S., Kenney S. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent. J. Virol. 64:1990;1817-1820.
36. Quinlivan E. B., Ye D., Wehbie R. S., Stewart P. W., Flepp M., Vernazza P. L. Kaposi's sarcoma patients in the Swiss HIV cohort study with and without detectable human herpesvirus 8 in peripheral blood mononuclear cells. AIDS. 11:1997;1893-1895.
37. Raab M. S., Albrecht J. C., Birkmann A., Yaguboglu S., Lang D., Fleckenstein B., Neipel F. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:1998;6725-6731.
38. Reed J. A., Nador R. G., Spaulding D., Tani Y., Cesarman E., Knowles D. M. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin d homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood. 91:1998;3825-3832.
39. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:1996;342-346.
40. Rickinson A., Kieff E. Epstein-Barr virus. Knipe D. Virology. 1996;2397-2446 Raven Press, Ltd. New York.
41. Russo J. J., Bohensky R. A., Chien M.-C., Chen J., Yan M., Maddelena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
42. Sarid R., Flore O., Bohenzky R. A., Chang Y., Moore P. S. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72:1998;1005-1012.
43. Silver P. A., Keegan L. P., Ptashine M. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. Sci. USA. 81:1984;5951-5955.
44. Sun R., Lin S.-F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 95:1998;10866-10871.
45. Sun R., Lin S.-F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:1999;2232-2242.
46. Whitby D., Howard M. R., Tenant-Flowers M., Brink N. S., Copas A., Boshoff C., Hatzigannou T., Suggett F. E. A., Aldam D. M., Denton A. S., Miller R. F., Weller I. V. D., Weiss R. A., Tedder R. S., Schulz T. F. Detection of Kaposi's sarcoma associated herpesvirus in perpheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 346:1995;799-802.
47. Whitehouse A., Carr I. M., Griffiths J. C., Meredith D. The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R proteins, is transcribed from two different promoters of different temporal phases. J. Virol. 71:1997;2550-2554.
48. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
49. Zalani S., Holley-Guthrie E. A., Gutsch D. E., Kenney S. C. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J. Virol. 66:1992;7282-7289.
50. Zhong W., Wang H., Herndier B., Ganem D. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA. 93:1996;6641-6646.